MA51982A - FORMULATION OF SLOW-RELEASE DRUGS WITH AN OUTER LAYER INCLUDING A POLYMER DEGRADABLE BY ENZYMES, ITS COMPOSITION AND ITS PRODUCTION PROCESS - Google Patents

FORMULATION OF SLOW-RELEASE DRUGS WITH AN OUTER LAYER INCLUDING A POLYMER DEGRADABLE BY ENZYMES, ITS COMPOSITION AND ITS PRODUCTION PROCESS

Info

Publication number
MA51982A
MA51982A MA051982A MA51982A MA51982A MA 51982 A MA51982 A MA 51982A MA 051982 A MA051982 A MA 051982A MA 51982 A MA51982 A MA 51982A MA 51982 A MA51982 A MA 51982A
Authority
MA
Morocco
Prior art keywords
enzymes
formulation
slow
composition
outer layer
Prior art date
Application number
MA051982A
Other languages
French (fr)
Inventor
González Roberto Carlos Bravo
Carsten Markus Füller
Felipe Varum
Rochow Laetitia Von
Original Assignee
Tillotts Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tillotts Pharma Ag filed Critical Tillotts Pharma Ag
Priority to MA051982A priority Critical patent/MA51982A/en
Publication of MA51982A publication Critical patent/MA51982A/en

Links

MA051982A 2018-12-07 2018-12-07 FORMULATION OF SLOW-RELEASE DRUGS WITH AN OUTER LAYER INCLUDING A POLYMER DEGRADABLE BY ENZYMES, ITS COMPOSITION AND ITS PRODUCTION PROCESS MA51982A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MA051982A MA51982A (en) 2018-12-07 2018-12-07 FORMULATION OF SLOW-RELEASE DRUGS WITH AN OUTER LAYER INCLUDING A POLYMER DEGRADABLE BY ENZYMES, ITS COMPOSITION AND ITS PRODUCTION PROCESS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MA051982A MA51982A (en) 2018-12-07 2018-12-07 FORMULATION OF SLOW-RELEASE DRUGS WITH AN OUTER LAYER INCLUDING A POLYMER DEGRADABLE BY ENZYMES, ITS COMPOSITION AND ITS PRODUCTION PROCESS

Publications (1)

Publication Number Publication Date
MA51982A true MA51982A (en) 2021-01-20

Family

ID=77561601

Family Applications (1)

Application Number Title Priority Date Filing Date
MA051982A MA51982A (en) 2018-12-07 2018-12-07 FORMULATION OF SLOW-RELEASE DRUGS WITH AN OUTER LAYER INCLUDING A POLYMER DEGRADABLE BY ENZYMES, ITS COMPOSITION AND ITS PRODUCTION PROCESS

Country Status (1)

Country Link
MA (1) MA51982A (en)

Similar Documents

Publication Publication Date Title
EP4248766A3 (en) Smokeless oral tobacco product and preparation thereof
EA201391053A1 (en) TABLET DISPERSED IN THE MOUTH CAVITY
AU2013328639A8 (en) Fast disintegrating solid dosage form formulation comprising functionalized calcium carbonate and method of their manufacture
BR112015016169A2 (en) featuring glatiramer acetate related drug products
EA201690207A1 (en) TRADITIONAL CHINESE MEDICINE COMPOSITION AND DRUGS AND THEIR APPLICATION
CL2008002394A1 (en) Cyclic depsipeptide, or derivatives, kallikrein 7 inhibitors, obtained from chondromyces crocatus, method of obtaining and therapeutic uses.
BR112017006113A8 (en) Auristatin uses, pharmaceutical compositions, dosage forms for cancer treatment and kits.
MX2022015606A (en) Immediate-release tablets containing a drug and processes for forming the tablets.
BR112019002007A2 (en) pharmaceutical compositions, process for manufacturing granules, process for manufacturing a pharmaceutical composition, process for preparing amorphous ipatasertib monohydrochloride, method for treating hyperproliferative disorders, use of a pharmaceutical composition and present invention
MX347401B (en) Composition of excipients and pharmaceutical forms with sustained release and increased bioavailability of antibacterial drugs, anticoccidial drugs and other drugs for commercial poultry and pigs.
MX2017015250A (en) Formation of cyclosporin a/cyclodextrin nanoparticles.
MA51982A (en) FORMULATION OF SLOW-RELEASE DRUGS WITH AN OUTER LAYER INCLUDING A POLYMER DEGRADABLE BY ENZYMES, ITS COMPOSITION AND ITS PRODUCTION PROCESS
BR112018010736A2 (en) antisense oligonucleotides against il-34 and methods of using them
TN2013000286A1 (en) Orally dispersible tablet
MA49464A (en) TARGETED DRUG RESCUE WITH NEW COMPOSITIONS, ASSOCIATIONS AND CORRESPONDING PROCESSES
GEP20247608B (en) Delayed release drug formulation comprising an outerlayer with an enzymaticyally degradable polymer, its composition and its method of manufacturing
BR112014018247A8 (en) AMORPHOUS AND STABLE RALTEGRAVIR POTASSIUM PREMIX; PROCESS; PHARMACEUTICAL FORMULATION; AND METHOD
MX2017004242A (en) Dissolution testing of hydrophobic active pharmaceutical ingredients such as avermectins with or without pyrantel.
MA54504A (en) KETOPROFEN CO-CRYSTAL, COMPOSITIONS COMPRISING IT, ITS PRODUCTION METHOD AND ITS USES
BR112016030243A2 (en) PHARMACEUTICAL DOSAGE FORMS, THEIR PREPARATION PROCESS, AND USES OF MICROCRYSTALLINE CELLULOSE
WO2017105212A3 (en) Biodegradable covalent matrices for the oral delivery of insulin directed to the colon, activated by microbiota, and production method thereof
TW201613645A (en) Long-acting, sustained drug delivery, injectable gel composition and fabricating method thereof
Grose SIMPLER DRUG-MAKING
MA52158A (en) KETOPROFEN CO-CRYSTAL, COMPOSITIONS INCLUDING IT, ITS PRODUCTION PROCESS AND ITS USES
Falk Foreword. Biologics of IBD